2021 Quality Care Symposium Planning Committee All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution Name Employment Leadership Stock and Other Honoraria Consulting or Advisory Speakers' Bureau Research Funding Patents, Royalties, Other Expert Testimony Travel, Accommodations, Other Relationship (OPTIONAL) (OPTIONAL) Open Ownership Interests Role Intellectual Property Expenses Uncompensated Payments Link Relationships Kerin B. Adelson Emilio Health- Emilio Health- Carrum Health, Emilio Genentech Celgene, HERON, Roche Genentech/Roche Genentech Celgene, Genentech, Genentech/Roche Brightline Health (I) Brightline Health (I) Health-Brightline Health (I), DIS HERON, Roche DIS Lyra Health (I), MindNest Heath (I) Neeraj K. Arora Fumiko Chino Varian (Inst) Janet De Moor Biogen (I) Biogen (I) Biogen (I) John T. Hamm BrightPath AstraZeneca, Meda Abbvie (Inst), Amgen (Inst), ARMO BioSciences (Inst), Astellas Biotheraputics, Exelixis, Pharmaceuticals, Pfizer Pharma (Inst), AstraZeneca (Inst), Boehringer Ingelheim (Inst), Puma Biotechnology Boston Biomedical (Inst), BrightPath Biotheraputics (Inst), Bristol- Myers Squibb (Inst), Cancer Research and Biostatistics (Inst), Celgene (Inst), Clovis Oncology (Inst), Daiichi Sankyo (Inst), Dana Farber Cancer Institute (Inst), Deciphera (Inst), EMD Serono (Inst), EpicentRx (Inst), Exact Sciences (Inst), Five Prime Therapeutics (Inst), G1 Therapeutics (Inst), GBG Forschungs (Inst), Genentech (Inst), Gilead Sciences (Inst), GlaxoSmithKline (Inst), Gynecologic Oncology Group (Inst), Halozyme (Inst), Immunicum (Inst), Incyte (Inst), Infinity Pharmaceuticals (Inst), Janssen (Inst), Jiangsu Hengrui Medicine (Inst), Johnson & Johnson (Inst), Lilly (Inst), MedImmune (Inst), Merck (Inst), Moffitt (Inst), National Surgical Adjuvant Breast and Bowel Project (Inst), Nektar (Inst), Novartis (Inst), OncoMed (Inst), Pfizer (Inst), PharmaMar (Inst), Plexxikon (Inst), Pronova (Inst), Roche (Inst), Sarah Cannon Research Institute (Inst), Seattle Genetics (Inst), Southwest Oncology Group (Inst), Spectrum Pharmaceuticals (Inst) Dawn L. Hershman AIM Specialty Health Haejin In Barbara Jagels Ryan D. Nipp Wynne Norton Raymond U. Osarogiagbon Gilead, Lilly, Pfizer Biodes American Cancer Society, 2 US and 1 China patent Oncobox Device Association of Community for lymph node specimen Cancer Centers (ACCC), collection kit and method of AstraZeneca, Triptych pathologic evaluation Health Partners Gabrielle B. Rocque Pfizer Carevive Systems, Genentech, Pfizer Carevive (I) Hanna K. Sanoff Bayer (Inst) Shanthi Sivendran Biomarker associated with risk of melanoma reoccurrence inventor (Inst) Cardinale B. Smith AstraZeneca Bristol-Myers Squibb Teva Stephanie B. Wheeler Pfizer Foundation (Inst) Pfizer Lalan S. Wilfong McKesson NCCN, Pfizer E.R. Squibb Sons Jean Wright Johns Hopkins ASTRO Oncospace Royalties from Up To Date Hospital (I) K R. Yabroff.